Evidence map›Paper›PMID 36247508›Full record

ArticleIranian journal of pathology2022

The Antibacterial and Anti-biofilm Traits of the Novel BMAP-27-Melittin Conjugated Peptide Nanoparticle Against

Mohammad Pourahmadi, Kimia Pourahmadi, Farzan Modaresi, Shekoufeh Atashpour, Azita Azad, Alireza Ranjbaran, Abdolmajid Ghasemian

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Iranian journal of pathology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 87% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 0 citations in OpenAlex.

  1. Therapeutic Bioactivity Exerted by theMolecules (Basel, Switzerland) · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Mohammad PourahmadiDepartment of Anatomical Sciences, Jahrom University of Medical Sciences, Jahrom, Iran.
Kimia PourahmadiStudent Research Committee, School of Dentistry, Shiraz University of Medical Sciences, Shiraz, Iran.
Farzan ModaresiDepartments of Microbiology, Advanced Medical Sciences and Technology, Jahrom University of Medical Sciences, Jahrom, Iran.
Shekoufeh AtashpourDepartments of Microbiology, Advanced Medical Sciences and Technology, Jahrom University of Medical Sciences, Jahrom, Iran.
Azita AzadOral and Dental Disease Research Center, Department of Oral & Maxillofacial Medicine, School of Dentistry, Shiraz University of Medical Sciences, Shiraz, Iran.
Alireza RanjbaranOral and Dental Disease Research Center, Department of Oral & Maxillofacial Medicine, School of Dentistry, Shiraz University of Medical Sciences, Shiraz, Iran.
Abdolmajid GhasemianNoncommunicable Diseases Research Center, Fasa University of Medical Sciences, Fasa, Iran.
Shiraz University of Medical Sciences · IRJahrom University of Medical Sciences · IRFasa University of Medical Sciences · IRJahrom University · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background & Objective: The spread and development of drug-resistant bacterial strains has prompted the hunt for novel antibacterial polypeptides undergoing conformational changes to confer rapid bactericidal effects. The aim of this study was to evaluate the effect of novel BMAP27-Melittin conjugated peptide- nanoparticle (NP) against Methods: Sixty subgingival plaque samples were collected, and 39 Results: Thirty-nine infected subjects were reported, including 24 males and 15 females ( Conclusion: BMAP27-Melittin-NP demonstrated significant antibacterial and anti-biofilm effects against clinical isolates of

Indexed as

Antimicrobial PeptideBiofilmsBMAP-27MelittinNanoparticlesStreptococcus mutans

Identifiers

PMID36247508
PMCPMC9508543
OpenAlexW4306667696

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.